Improving outcomes in MASLD: the role of Helicobacter pylori eradication and lifestyle interventions–author's response to Zhang
Year: 2025
Type: article
Abstract: We thank Dr. Zhang for the interest in our study1 and for noting that the study provides valuable insights into the association between Helicobacter pylori and metabolic dysfunction-associated steatotic liver disease (MASLD) and related conditions. We would like to take the opportunity to address several issues raised by Dr. Zhang.
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,930
Funders: Office of Dietary Supplements, University of Miami, Northwestern University, San Diego State University, National Institutes of Health, Albert Einstein College of Medicine, Yeshiva University, University of North Carolina Wilmington, University of Illinois at Chicago, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute on Deafness and Other Communication Disorders, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, National Institute of Dental and Craniofacial Research
OpenAlex ID: W4409115081
